Welcome!
The ASHP-accredited PGY2 Oncology Pharmacy Residency offers a unique and stimulating learning environment that provides comprehensive clinical training in hematology and oncology pharmacy practice. The program develops clinical practitioners who specialize in the care of oncology patients and who have an interest in education and research. After orientation, residents complete 10 months of clinical rotations, along with longitudinal experiences in our outpatient infusion center and clinics, teaching, and clinical research.
Oncology-specific practice environment
- Nebraska Medicine | Fred & Pamela Buffett Cancer Center is nationally respected and is a founding member of the National Comprehensive Cancer Network (NCCN).
- Supported by the University of Nebraska Medical Center (UNMC), the primary research and academic partner of Nebraska Medicine, the Fred & Pamela Buffett Cancer Center combines leading-edge research, education, and patient care to offer the most up-to-date treatments for a variety of cancers.
- This unique collaboration allows discoveries made in the laboratories to move directly to patient care.
- We are recognized internationally for pioneering autologous transplantation for lymphoma, the use of peripheral stem cells as an alternative rescue product, groundbreaking studies on various growth factors, and transplants in alternate settings other than traditional inpatient hospital units.
- Our outpatient transplant program empowers patients and their care partners to play an active role in the treatment and recovery process following cancer care.
Rotational experiences
Required rotations
Orientation (4 weeks, July)
BMT/Leukemia/Lymphoma/Cellular Therapy (6 weeks)
Medical Oncology/Hematology (2 weeks)
Pediatric Hematology/Oncology (4 weeks)
Infusion Center (4 weeks)
Ambulatory Oncology Clinic – BMT/Malignant Hematology (8 weeks)
Ambulatory Oncology Clinic – Solid Tumors (8 weeks)
Elective rotations
Pain Management/Palliative Care (2 to 4 weeks)
Disease-Specific Ambulatory Clinic (2 to 4 weeks)
Benign Hematology (2 to 4 weeks)
BMT/Leukemia/Lymphoma/Cellular Therapy (2 to 4 weeks)
Medical Oncology/Hematology (2 to 4 weeks)
Infusion Center (2 to 4 weeks)
Specialty Pharmacy (2 weeks)
Longitudinal rotations
Oncology Pharmacy Management (52 weeks, including 2 weeks of focused experience, July through June)
Drug Policy/Formulary Management (52 weeks, July through June)
Research (52 weeks, July through June)
Oncology Residency Conference/Teaching (52 weeks, July through June)
Investigational Drug Service (52 weeks, July through June)
Ambulatory Oncology Clinic (Solid and BMT/Malignant Hematology) (48 weeks, August through June)
Leadership Development Series (36 weeks, August through April, if not completed during PGY1)
Service commitment (staffing) experience (52 weeks, July through June)
PGY2 residents are required to fulfill the service commitment (staffing) designed to ensure they gain experience and can function as competent clinical oncology practitioners. Residents will train with preceptors, with basic training taking place during the first month of residency.
The service commitment includes the following requirements:
1. PGY2 oncology residents staff 32 shifts annually, including approximately two weekday evening shifts per month and every eighth weekend day shift
2. PGY2 oncology residents are required to work one holiday
3. Staffing responsibilities are completed in the C.L. Werner Cancer Hospital Oncology - Hematology Special Care Unit
Contact
David Hartnett-Quach, PharmD, BCOP
Oncology Pharmacist Specialist
PGY2 Oncology Residency Program Director
Nebraska Medicine
981090 Nebraska Medical Center
Omaha, NE 68198-1090
Phone: 402.552.0944
Jared Matya, PharmD, BCOP
Clinical Pharmacist Practitioner – Blood and Marrow Transplant
PGY2 Oncology Assistant Residency Program Director
Nebraska Medicine
981090 Nebraska Medical Center
Omaha, NE 68198-1090
Phone: 402.552.3929